Port delivery system with ranibizumab (susvimo) recall- what does it mean to the retina specialists

HIGHLIGHTS

• who: Ashish Sharma from the India Associates, The University of Nevada, Reno School have published the article: Port delivery system with ranibizumab (Susvimo) recall- What does it mean to the retina specialists, in the Journal: (JOURNAL) of August/31,/2022
• future: This drastically improved the incidence of vitreous hemorrhage in the later part of phase 2 and future trials. Unlike the brolucizmuab inflammation safety issues which cannot mitigated it is hoped that since Susvimo has undergone a voluntary recall and it is related to quality testing this will be rectified in the near future and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.